SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006041
Filing Date
2018-05-01
Accepted
2018-05-01 08:01:21
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 746868
2 ex10-4.htm EX-10.4 41638
3 ex31-1.htm EX-31.1 18466
4 ex31-2.htm EX-31.2 11641
5 ex32-1.htm EX-32.1 4132
6 ex32-2.htm EX-32.2 4301
7 image_001.jpg GRAPHIC 22131
  Complete submission text file 0001493152-18-006041.txt   2834783

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE vbiv-20180331.xml EX-101.INS 335625
9 XBRL SCHEMA FILE vbiv-20180331.xsd EX-101.SCH 46914
10 XBRL CALCULATION FILE vbiv-20180331_cal.xml EX-101.CAL 56404
11 XBRL DEFINITION FILE vbiv-20180331_def.xml EX-101.DEF 103658
12 XBRL LABEL FILE vbiv-20180331_lab.xml EX-101.LAB 259471
13 XBRL PRESENTATION FILE vbiv-20180331_pre.xml EX-101.PRE 180039
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 18793270
SIC: 2834 Pharmaceutical Preparations